If phase 3 trial results are confirmed, a novel once-weekly pill platform could transform daily medications into weekly ...

Advances in technology have made surgery for drug-resistant epilepsy more precise — and could help identify surgical ...

A study using data from a European registry shows cashew as the most frequent elicitor of tree nut-induced anaphylaxis in ...

At HLTH Europe 2025, experts warned that stigma, cost barriers, and lack of support are hindering the wider use of GLP-1s in ...

Your patient has waited 4 weeks for a 15-minute visit, and you’re double-booked and distracted. As physician shortages ...

Uncover the ‘treatable traits’ concept and how it’s reshaping treatment strategies for better patient management.

Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

The American College of Physicians calls for better evidence but does not seek to put a stop to the use of the measures.

From full-sugar sodas to smoothies and booze, hidden calories and sugars are easy to pile up. Here’s how to warn your ...

Azacitidine shows promising effectiveness and favorable glucocorticoid-sparing effects in patients with genetically confirmed ...

When antihistamines and steroids fall short, doctors should consider the hidden neuropathic cause of stubborn summer itching.

Compared with other systemic agents for treating atopic dermatitis, dupilumab is associated with an increased risk for ...